Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

2.53USD
15 Feb 2019
Change (% chg)

$0.06 (+2.43%)
Prev Close
$2.47
Open
$2.49
Day's High
$2.59
Day's Low
$2.49
Volume
17,776
Avg. Vol
21,603
52-wk High
$8.55
52-wk Low
$1.96

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.492
Jun '18 0.00 -1.129
Mar '18 0.00 -0.802
FY 2017 Dec '17 0.00 -0.688
Sep '17 0.00 -0.727
Jun '17 0.00 -0.989
Mar '17 0.00 -0.798
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 0.00 0.00 0.00 0.92
Earnings (per share)
Quarter Ending Mar-19 2 -0.54 -0.52 -0.55 -0.50
Quarter Ending Jun-19 2 -0.44 -0.35 -0.53 -0.50
Year Ending Dec-19 4 -1.99 -1.62 -2.24 -2.59
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 2.01 10.14 5.26
Price to Tangible Book (MRQ) 2.01 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 83.64 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -16.70 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -21.07 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 7.49 3.50 3.08
LT Debt to Equity (MRQ) 14.96 18.65 11.38
Total Debt to Equity (MRQ) 16.05 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.40 12.87
Operating Margin (TTM) -- -184.63 6.20
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -- -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.68 8.61
Net Profit Margin (TTM) -- -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,654,601 842,398,385
Net Income/Employee (TTM) -944,400 562,114 99,842,801
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.20 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -72.93 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -77.58 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -42.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cidara Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 10.61 6.79 70 99
13 Week 0.69 -4.21 52 95
26 Week 1.39 -6.32 55 98
52 Week -35.34 -45.20 27 72
YTD -29.81 -38.36 21 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 72.72%
# of Holders: 66
Total Shares Held: 20,181,463
3 Mo. Net Change: -896,933
# New Positions: 1
# Closed Positions: 10
# Increased Positions: 17
# Reduced Positions: 25
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.